Mantle cell lymphoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Mantle cell lymphoma}} | {{Mantle cell lymphoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Akram}} | ||
==Overview== | ==Overview== |
Revision as of 15:40, 5 November 2018
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma historical perspective On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma historical perspective |
Risk calculators and risk factors for Mantle cell lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2]
Overview
Historical Perspective
Discovery
- In 1964, Lennert first described the disease as centrocytic lymphoma.
- In 1992, Banks first coined the term Mantle Cell Lymphoma (MCL). In 1994, MCL was included into the Revised European-American Classification of Lymphoid Neoplasms (REAL) classification.
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
Outbreaks
There have been several outbreaks of [disease name], which are summarized below:
Landmark Events in the Development of Treatment Strategies
In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
Impact on Cultural History
Famous Cases
The following are a few famous cases of disease name: